User:Swunalightyear/sandbox: Difference between revisions
Appearance
Content deleted Content added
New Jersey bill |
New York bill |
||
Line 8: | Line 8: | ||
* '''Illinois'''. The [[Illinois Opioids-Covid-19-Naloxone Resolution]], a legislative bill that is still working its way through the Illinois State Senate<ref>{{Cite web|title=Illinois General Assembly - Bill Status for SR1184|url=http://www.ilga.gov/legislation/BillStatus.asp?DocNum=1184&GAID=15&DocTypeID=SR&SessionID=108&GA=101|access-date=2020-06-14|website=www.ilga.gov}}</ref>, if passed would urge the state to study the increase in opiate overdose deaths in Illinois and would urge the state to propose changes to prescription rules to include co-prescription of naloxone to patients in high-risk groups of overdose.<ref>{{Cite web|title=Illinois General Assembly - Full Text of SR1184|url=http://www.ilga.gov/legislation/fulltext.asp?DocName=&SessionId=108&GA=101&DocTypeId=SR&DocNum=1184&GAID=15&LegID=&SpecSess=&Session=|access-date=2020-06-14|website=www.ilga.gov}}</ref> |
* '''Illinois'''. The [[Illinois Opioids-Covid-19-Naloxone Resolution]], a legislative bill that is still working its way through the Illinois State Senate<ref>{{Cite web|title=Illinois General Assembly - Bill Status for SR1184|url=http://www.ilga.gov/legislation/BillStatus.asp?DocNum=1184&GAID=15&DocTypeID=SR&SessionID=108&GA=101|access-date=2020-06-14|website=www.ilga.gov}}</ref>, if passed would urge the state to study the increase in opiate overdose deaths in Illinois and would urge the state to propose changes to prescription rules to include co-prescription of naloxone to patients in high-risk groups of overdose.<ref>{{Cite web|title=Illinois General Assembly - Full Text of SR1184|url=http://www.ilga.gov/legislation/fulltext.asp?DocName=&SessionId=108&GA=101&DocTypeId=SR&DocNum=1184&GAID=15&LegID=&SpecSess=&Session=|access-date=2020-06-14|website=www.ilga.gov}}</ref> |
||
* '''New Jersey'''. Still pending in the state Senate, the [[New Jersey Opioid Antidote Prescription Bill]] would require a co-prescription of naloxone or other opioid overdose agent with prescriptions for opioid medications for all patients who have a high risk of overdosing and tightens restrictions on the dispensing of opioid medications within the state.<ref>https://www.njleg.state.nj.us/2020/Bills/S2500/2323_I1.PDF</ref> Note that this is a distinction from other bills, which would merely allow or suggest co-prescription; in this bill, it would be required. |
* '''New Jersey'''. Still pending in the state Senate, the [[New Jersey Opioid Antidote Prescription Bill]] would require a co-prescription of naloxone or other opioid overdose agent with prescriptions for opioid medications for all patients who have a high risk of overdosing and tightens restrictions on the dispensing of opioid medications within the state.<ref>https://www.njleg.state.nj.us/2020/Bills/S2500/2323_I1.PDF</ref> Note that this is a distinction from other bills, which would merely allow or suggest co-prescription; in this bill, it would be required. |
||
* '''New York'''. A bill introduced in New York, the [[New York Mandatory Opioid Antagonist Prescription Bill]], would require doctors and other prescribers to co-prescribe an opioid antagonist agent with the first opioid prescription of the year for certain high-risk patients.<ref>https://legislation.nysenate.gov/pdf/bills/2019/S5150B</ref> |
|||
* '''New York'''. |
|||
* '''South Carolina'''. |
* '''South Carolina'''. |
||
Revision as of 13:42, 10 September 2020
State legislation
Legislators in several U.S. states have pushed changes to state laws regarding naloxone co-prescribing. Many have passed and were signed into law. Examples include:
- California. Signed into law in 2018, the California Naloxone Requirement Bill requires medical prescribers to offer a prescription for naloxone (or equivalent) to certain populations at higher risk of overdosing from opiate drugs.[1]
- Colorado. The Colorado Harm Reduction Substance Use Disorders Law requires that the cost of opioid antagonists such as Narcan and Evzio be covered by health insurance.[2][3]
- Illinois. The Illinois Opioids-Covid-19-Naloxone Resolution, a legislative bill that is still working its way through the Illinois State Senate[4], if passed would urge the state to study the increase in opiate overdose deaths in Illinois and would urge the state to propose changes to prescription rules to include co-prescription of naloxone to patients in high-risk groups of overdose.[5]
- New Jersey. Still pending in the state Senate, the New Jersey Opioid Antidote Prescription Bill would require a co-prescription of naloxone or other opioid overdose agent with prescriptions for opioid medications for all patients who have a high risk of overdosing and tightens restrictions on the dispensing of opioid medications within the state.[6] Note that this is a distinction from other bills, which would merely allow or suggest co-prescription; in this bill, it would be required.
- New York. A bill introduced in New York, the New York Mandatory Opioid Antagonist Prescription Bill, would require doctors and other prescribers to co-prescribe an opioid antagonist agent with the first opioid prescription of the year for certain high-risk patients.[7]
- South Carolina.
See also
- California Naloxone Requirement Bill
- Illinois Opioids-Covid-19-Naloxone Resolution
- New Jersey Opioid Antidote Prescription Bill
- New York Mandatory Opioid Antagonist Prescription Bill
- South Carolina Opioid Overdose Prevention Bill
References
- ^ "Bill Text - AB-2760 Prescription drugs: prescribers: naloxone hydrochloride and other FDA-approved drugs". leginfo.legislature.ca.gov. Retrieved 2020-07-22.
- ^ Severance, Ryan. "Colorado bills addressing opioid crisis signed into law". The Pueblo Chieftain. Retrieved 2020-09-02.
- ^ "Harm Reduction Substance Use Disorders | Colorado General Assembly". leg.colorado.gov. Retrieved 2020-09-02.
- ^ "Illinois General Assembly - Bill Status for SR1184". www.ilga.gov. Retrieved 2020-06-14.
- ^ "Illinois General Assembly - Full Text of SR1184". www.ilga.gov. Retrieved 2020-06-14.
- ^ https://www.njleg.state.nj.us/2020/Bills/S2500/2323_I1.PDF
- ^ https://legislation.nysenate.gov/pdf/bills/2019/S5150B